{"schema_version":"secwatch.filing_event.v1","accession":"0001757073-22-000060","form_type":"8-K","ticker":"NVST","cik":"0001757073","company_name":"Envista Holdings Corp","filed_at":"2022-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.187036+00:00","generated_at":"2026-06-26T00:51:43.359412+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Envista Q1 sales $631.4M, core growth 5.4%, completes IOS acquisition","bullets":["Q1 sales $631.4M (+3.1% as-reported, +5.4% core growth YoY).","GAAP diluted EPS $0.39; adjusted diluted EPS $0.47 vs $0.49 in Q1 2021.","Adjusted EBITDA $124.6M (19.7% margin) vs $132.3M prior year.","Completed acquisition of Carestream Dental's intraoral scanner business; expects $35-45M IOS sales in 2022.","FY2022 guidance: core sales growth 6-8%, adj. EBITDA margin >20%; Q2 mid-single digit core growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001757073-22-000060","json":"https://secwatch.observer/filing/0001757073-22-000060.json","markdown":"https://secwatch.observer/filing/0001757073-22-000060.md","text":"https://secwatch.observer/filing/0001757073-22-000060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757073/000175707322000060/0001757073-22-000060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757073/000175707322000060/nvst-20220504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T00:51:43.359412+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}